0001104659-14-022920.txt : 20140326 0001104659-14-022920.hdr.sgml : 20140326 20140326160528 ACCESSION NUMBER: 0001104659-14-022920 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140320 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20140326 DATE AS OF CHANGE: 20140326 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Xencor Inc CENTRAL INDEX KEY: 0001326732 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201622502 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36182 FILM NUMBER: 14718698 BUSINESS ADDRESS: STREET 1: 111 WEST LEMON AVE CITY: MONROVIA STATE: CA ZIP: 91016 BUSINESS PHONE: 626-305-5900 MAIL ADDRESS: STREET 1: 111 WEST LEMON AVE CITY: MONROVIA STATE: CA ZIP: 91016 8-K 1 a14-8828_18k.htm 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 20, 2014

 

 

XENCOR, INC.

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

001-36182

 

20-1622502

(State of incorporation)

 

(Commission File No.)

 

(IRS Employer Identification No.)

 

111 West Lemon Avenue

Monrovia, California 91016

(Address of principal executive offices and zip code)

 

Registrant’s telephone number, including area code: (626) 305-5900

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o                 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o                 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o                 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o                 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 5.02                                           Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

(b)  On March 20, 2014, Harold R. Werner notified Xencor, Inc. (the “Company”) of his resignation from the Board of Directors of the Company, (the “Board”) effective immediately. To fill the vacancies created by Mr. Werner’s resignation, the Board appointed (i) Dr. Bruce L.A. Carter, one of its existing directors, as a member of the Audit Committee of the Board and as chairman of the Compensation Committee of the Board and (ii) Robert F. Baltera, Jr., one of its existing directors, as a member of the Nominating and Corporate Governance Committee of the Board.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date: March 26, 2014

XENCOR, INC.

 

 

 

By:

/s/ Bassil I. Dahiyat, Ph.D.

 

 

Bassil I. Dahiyat, Ph.D.

 

 

President and Chief Executive Officer

 

3